rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

BranchOut Food Inc.

BOF · Nasdaq

Consumer StaplesFood ProductsNot moving yet

BOF stood above a rising 150-day average in 46 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 42.8% below that average now. Food Products: 18% of its 55 stocks in an uptrend (−7 points in four weeks); Consumer Staples: 24% (+1 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 2
Industry in uptrend
18% -7 in 4 wk
Insider buys, 12 months
$304
Insider sales, 12 months
$10.4M
Officials’ trades on record
0
Institutions holding
25 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 46 of 52 weeks.

17 Apr – 16 Oct
10%22%35%Apr 26Jun 26Jul 26Sep 26Oct 26

Food Products: Few of its stocks are in an uptrend and the share has been slipping. Consumer Staples: A minority of its stocks are in an uptrend and the share has held steady.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$7.0M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months4
Buyers · sellers1 · 2
WhoDidSharesTraded
Byron Riche JonesDirectorbought45at $3.3816 Jun 2026filed 16 Jun 2026
Daniel Louis Kaufman10% ownersold1,189,676at $3.062 Jun 2026filed 4 Jun 2026
Daniel Louis Kaufman10% ownersold213,830at $3.2612 May 2026filed 14 May 2026
Daniel Louis Kaufman10% ownersold255,951at $3.295 May 2026filed 7 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders25+2 on the quarter
New · exited5 · 3
Reported value$19.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
KENNEDY CAPITAL MANAGEMENT LLCnew · filed 14 Aug 20261,201,458$5.5M+1,201,458
BARD ASSOCIATES INCreduced · filed 12 Aug 20261,030,329$4.7M-4,271−0.4%
STIFEL FINANCIAL CORPadded · filed 12 Aug 2026616,300$2.8M+62,031+11.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026398,019$1.8M+25,803+6.9%
SEI INVESTMENTS COreduced · filed 14 Aug 2026157,210$723K-15,194−8.8%
Informed Momentum Co LLCreduced · filed 13 Aug 2026136,047$626K-5,598−4.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026117,711$541K+13,044+12.5%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026111,400$512K+30,973+38.5%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026109,559$504K+94,959+650.4%
CORSAIR CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026100,000$460K00.0%
30 Jun 2023 – 30 Jun 2026
41424Jun 23Mar 24Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Byron Riche Jones Company insiderDirector · last 16 Jun 20264 · 0
Daniel Louis Kaufman Company insider10% owner · last 2 Jun 20260 · 3
Kaufman Kapital Llc Company insider10% owner · last 12 May 20260 · 1
Deven Jain Company insiderDirector · last 10 Feb 20260 · 0
Eric Healy Company insiderChief Executive Officer · last 10 Feb 20262 · 0
Greg Somerville Company insiderDirector · last 10 Feb 20260 · 0
Lindsey Schwartz Company insiderDirector · last 10 Feb 20260 · 0
John Dalfonsi Company insiderChief Financial Officer · last 12 Jun 20253 · 0
David Richard Israel Company insiderDirector · last 14 Apr 20250 · 0
Christopher Pierce Coulter Company insiderChief Financial Officer · last 24 Oct 20230 · 0

Same industry

UTZ Utz BrandsLeading+38%
MED MedifastIn trend+5%
LW Lamb Weston HoldingsJust started moving+16%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202514.8%
Operating profit marginFY 2025 · to 31 Dec 2025-39.1%
Free cash flow marginFY 2025 · to 31 Dec 2025-56.4%
Return on capital employedFY 2025 · to 31 Dec 2025-65.5%
Debt to equityFY 2025 · to 31 Dec 20251.59×
Interest coverFY 2025 · to 31 Dec 2025-6.87×
Research spendFY 2025 · to 31 Dec 20252.0%
Share count trendFY 2025 · to 31 Mar 20268.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$0
Free cash flowFY 2025 · to 31 Dec 2025−$7.7M

Analyst forecasts

No analyst forecasts yet.